HOPEWELL, N.J., Aug. 11, 2025 /PRNewswire/ -- ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, today announced...
- Supporting Korean Startups' Drug Discovery Research and Global Expansion -
- First Pharmaceutical Company from Japan to Actively Support the Operation of the Program...
"Comprehensive Review Highlights Market Growth, Innovation, and Investment Trends Driving the Future of Cell and Gene Therapy Tools, Biomanufacturing, and Gene Synthesis"
BOSTON, June 20, 2025...